NOT KNOWN DETAILS ABOUT AML WALLET RISK CHECK

Inspite of accomplishing an entire response with ideal induction therapy, negligible residual disease typically persists, necessitating consolidation therapy to mitigate the risk of relapse by getting rid of residual disorder. In clients who may have received seven+3 induction therapy, consolidation therapy is initiated with substantial-dose cytar